Healthcare DIVE May 22, 2024
A MEDCAC panel found time in range was an “extremely important” metric, but members were divided on whether quality of life measures should influence coverage.
A health advisory committee recommended that Medicare consider measures such as time in range and safety data when making coverage decisions about diabetes devices. In a Tuesday meeting, the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) discussed what clinical endpoints the CMS should ask for on devices used to manage Type 1 diabetes and insulin-dependent Type 2 diabetes in older adults.
The CMS convened the panel because devices used to monitor and control glucose levels, such as continuous glucose monitors and insulin pumps, have not been studied as much in seniors, and insulin-dependent...
Today's Sponsors
Today's Sponsor